Press Releases
moreFrontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
moreChemical & Engineering News Names Frontier Medicines One of Its 10 Chemistry Start-Ups to Watch
moreFierceBiotech Names Frontier Medicines One of Its “Fierce 15” Biotech Companies of 2019
moreFrontier Medicines Announces Three Executive Hires: Chief Scientific Officer, Chief Technology Officer & Head of Degrader Technologies
moreFrontier Medicines Launches with $67 Million to Develop Novel Medicines that Drug the “Undruggable” Targets Driving Human Disease
more
Presentations
UPCOMING EVENTS
No upcoming events.
PAST EVENTS
JP Morgan Healthcare Conference
January 13, 2021 - 2:35 pm EST
Webcast
Select Media Coverage
2020
December 3, 2020
BioSpace: Frontier and AbbVie Team Up Against Elusive Protein Targets
Read article
December 3, 2020
Fierce Biotech: AbbVie Pays Frontier $55M to Pursue Hard-to-Drug Targets
Read article
December 2, 2020
BioWorld: In Rugged E3 Space, AbbVie Delivers Frontier Justice – the Good Kind – via $1B-Plus Deal
Read article
December 2, 2020
Endpoints News: AbbVie Eyes Cancer, Immunology in Latest Protein Degradation Pact, Handing Frontier Medicines $55M Upfront
Read article
2019
November 11, 2019
C&EN: C&EN Names Frontier 2019 10 Start-Ups to Watch
Read article
September 23, 2019
FierceBiotech: FierceBiotech Names Frontier Medicines One of Its “Fierce 15” Biotech Companies of 2019
Read article
June 26, 2019
BioCentury: Frontier Aims for Previously Unreachable 'Hot Spot' Targets with $67M Series A
Read article
June 26, 2019
BioWorld: Frontier Medicines Launches with a $67M Series A Round
Read article
June 26, 2019
WSJ Venture Capital: Biotech Entrepreneur Chris Varma Scores $67 Million for Frontier Medicines
Read article
Media Center
MEDIA CONTACT
Alexandra Santos
pr@frontiermeds.com
LOGOS
Right click and choose “Save Link As” to download a high resolution image.
